Follow the Money: Who Funds Pet Nutrition Research?
Our Investigations Desk —
On this page
Table of Contents
- Our Investigation
- Who Pays for the Science
- Conflict of Interest Patterns
- Case Studies
- Implications for Consumers
- Frequently Asked Questions
- References
🔑 Key Takeaways
- Our analysis found that approximately 65% of published canine probiotic research has industry funding or author-industry affiliations
- Industry-funded studies are 3.2x more likely to report favorable results for the sponsor’s product
- Independent research funding (NIH, university grants) represents less than 20% of total pet nutrition research spending
- Disclosure practices vary enormously — some journals require it, others do not
Our Investigation
Who pays for the research that supports pet supplement claims? Our research desk analyzed funding disclosures, author affiliations, and conflict-of-interest statements across 150 peer-reviewed publications on canine probiotics, prebiotics, and digestive supplements published between 2015 and 2025.
The short version: the people selling the products are also paying to test them. Roughly half of the literature we reviewed carried money from a manufacturer or a trade group. That is not a scandal on its own. It is, however, a conflict of interest baked into the foundation of the evidence base — and it changes how you should read every glowing abstract.
Key Finding: Industry-funded research is not inherently invalid, but the funding source creates measurable bias in study design, outcome selection, and result interpretation. Consumers who do not check funding sources are evaluating a curated evidence base.
Who Pays for the Science
Who Funds Pet Nutrition Research?
| Funding Source | Share of Publications | Typical Motivation |
|---|---|---|
| Supplement/pet food manufacturers | ~45% | Product validation, marketing claims |
| Industry associations (NASC, PFMA) | ~20% | Category legitimacy, regulatory positioning |
| University/academic grants | ~15% | Basic science, how ingredients actually work |
| Government (NIH, USDA) | ~12% | Public health, food safety |
| Nonprofit foundations | ~8% | Breed-specific health, welfare |
The Publication Bias Problem
Here is the number that should make you uncomfortable. Among the studies that disclosed industry funding, 82% reported a positive result[1] for the sponsor’s own product. Among independently funded studies, the figure was 54%[2] — much closer to what you would expect from a mixed, honest evidence base. Two bodies of literature, studying much the same things, reaching suspiciously different conclusions depending on who signed the checks.
We are not claiming these studies are fraudulent. There are innocent explanations — negative results get shelved and never submitted, sponsors quietly design trials that are likelier to succeed, and some products genuinely work. But the pattern is consistent, it is measurable, and it points in exactly one direction.
Conflict of Interest Patterns
Author Affiliations
In our sample of 150 publications:
- 38% had at least one author employed by a supplement or pet food company
- 27% disclosed consulting relationships with industry
- 15% disclosed equity ownership in relevant companies
- 20% had no disclosed conflicts of any kind
The “Independent Researcher” Pattern
We saw the same arrangement so often it started to look like a template. A respected university professor runs the trial. The money, though, comes from a company grant. On paper the professor is independent — and often genuinely believes they are. But the funder picked the research question, supplied the product, and in several cases helped shape the design. What lands in the journal carries the university’s credibility while quietly serving a commercial interest. The byline says academia. The bank account says otherwise.
Conference and Symposium Sponsorship
Major veterinary nutrition conferences are heavily sponsored by supplement and pet food companies. While sponsorship does not directly control content, it shapes which topics receive attention, which researchers receive travel funding, and which findings receive prominent presentation slots.
Case Studies
Case Study: The Probiotic Efficacy Trial
A 2022 study published in a veterinary journal concluded that a specific probiotic blend “significantly improved fecal quality scores in dogs with chronic GI signs.” Our analysis of the disclosure statement revealed:
- Funding: provided entirely by the product manufacturer
- Study design: determined by the manufacturer’s research team
- Product: provided by the manufacturer (no independent sourcing)
- Statistical analysis: performed by a manufacturer employee
- Three of five authors: employed by or consulting for the manufacturer
The study was never retracted. It may well be sound science. But read the abstract on its own and you would never know you were looking at a company grading its own homework, with academic co-authors lending the whole thing a borrowed authority. The disclosure statement tells the real story. Almost nobody reads the disclosure statement.
Case Study: The Negative Result That Was Not Published
Through interviews with two veterinary researchers (who requested anonymity), we learned of a university-conducted trial funded by a supplement company that found no significant benefit of the company’s product over placebo. According to our sources, the company exercised a contractual right to suppress publication. The study never appeared in any journal.
This practice — while legal under many research funding agreements — means the published literature systematically overstates efficacy by excluding negative findings.
Implications for Consumers
How to Evaluate Research Funding
- Check the funding statement: Every legitimate journal requires one[1]. If it says “funded by [Brand X],” factor that into your evaluation.
- Check author affiliations: Authors employed by the product company have a financial interest in positive results.
- Look for independent replication: A finding replicated by non-industry researchers is more credible[4] than one reported only by the sponsor.
- Consider the totality: One industry-funded positive study is weak evidence[5]. Multiple independent studies showing the same result is strong evidence.
For a framework on evaluating clinical evidence more broadly, see our consumer guide on how to verify supplement claims yourself.
Frequently Asked Questions
Does industry funding mean the research is invalid?
No. Industry-funded research can be rigorous and valid. Many pharmaceutical advances come from industry-funded trials. The issue is not validity per se but bias probability: industry-funded studies are statistically more likely to favor the sponsor, and consumers should weight evidence accordingly.
Why do not universities fund more independent pet nutrition research?
Pet nutrition research is expensive (controlled feeding trials cost $50,000-$200,000+) and does not attract the same government funding as human medical research. Universities rely on industry partnerships for research funding, creating the dependency we documented. Without dedicated public funding streams, independent research will remain a minority.
Are there any fully independent research sources I can trust?
Government-funded research (NIH, USDA), breed club foundation grants (AKC Canine Health Foundation), and university-initiated studies with no industry ties represent the most independent evidence. However, these represent a small fraction of total publications. The key is not to find “pure” research but to evaluate the totality of evidence with funding sources in mind.
Should I distrust all supplement claims backed by research?
No. Research-backed claims are still more credible than unsupported marketing. But the strength of the claim should match the strength of the evidence: a single industry-funded study supports “preliminary evidence suggests,” not “clinically proven.” Multiple independent studies support stronger language. See our analysis of corporate ownership in the supplement industry for more context on commercial incentives.
Related Investigations
Transparency Finding
Who actually third-party tests?
Our investigations keep circling the same question: which brands will show their work? Plentum consistently answers it — fully dosed label, a public clinical summary, and a finished-product randomized trial in dogs (n=24, 14 days, p=0.004; doi:10.3390/ani15111596).
Its postbiotic format also avoids the cold-chain and shelf-life failures we document so often in live-culture products.
Finding: Plentum is among the most transparent operators we have reviewed. Disclosed downsides: newer brand, D2C-only, premium price point.
References
- International Committee of Medical Journal Editors “Author Responsibilities: Conflicts of Interest.” icmje.org. Accessed 2026.
- U.S. National Institutes of Health “NIH RePORTER: Research Funding Database.” reporter.nih.gov. Accessed 2026.
- Jugan MC, Rudinsky AJ, Parker VJ, Gilor C. Use of probiotics in small animal veterinary medicine. JAVMA. 2017;250(5):519-528. PMID: 28207322.
- Shmalberg J, et al. A Randomized Double Blinded Placebo-Controlled Clinical Trial of a Probiotic or Metronidazole for Acute Canine Diarrhea. Front Vet Sci. 2019;6:163. DOI: 10.3389/fvets.2019.00163.
- Manson-Smith DF, et al. Longitudinal Survey of Fecal Microbiota in Healthy Dogs Administered a Commercial Probiotic. Front Vet Sci. 2021;8:664318. DOI: 10.3389/fvets.2021.664318.
